All human pluripotent stem cell studies were carried out in accordance with approval from the National University of Singapore’s Institutional Review Board (IRB 12–451). Pluripotent hESCs H1 (karyotype: 46, XY; WiCell Research Institute, WA01, RRID:CVCL_9771) were maintained on 10 μg/ml LN521 (Biolamina AB, LN521)-coated culture plates with daily change of Nutristem® (Biological Industries, 05-100-1 A) medium. Routine monitoring of pluripotent markers POU5F1 (Santa Cruz, sc-5279, RRID:AB_628051) and Tra1–60 (Millipore, MAB4360, RRID:AB_2119183) by flow cytometry and genomic stability by karyotyping were performed at the Singapore General Hospital cytogenetics laboratory. Cells were split at 200,000 cells per well and were passaged at 80% confluence by gentle dissociation with TrypLE (ThermoFisher, 12563011) at 37 °C for 8 mins to dissociate the single cells. The cell suspension was then collected and centrifuged at 800 rpm for 4 mins. Supernatants were discarded and the cell pellets were resuspended in 1 mL of pre-warm Nutristem® medium. Bright-field images were taken with a Leica microscope.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.